Dermabrasion and Microneedling Market Expected to Reach $684.4 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Dermabrasion and Microneedling Market," The dermabrasion and microneedling market size was valued at $417.69 million in 2021 and is estimated to reach $684.40 million by 2031, exhibiting a CAGR of 5.1% from 2022 to 2031. Dermabrasion is a minimal invasive procedure which uses a rapidly rotating device to remove the outer layer of skin. It is used to treat fine lines, wrinkle, sun-damaged skin, and scar caused by acne, injury, accident, or previous surgery. Microneedling, also known as skin needling or collagen induction therapy, is a skin care treatment which use tiny needle to create micro-injury in the skin, and encourage the skin to produce more collagen and elastin. This treatment is mostly used for various skin issues such as acne scar, fine line & wrinkle, uneven skin tones, and reduce skin elasticity.

The major factors driving the growth of the global dermabrasion and microneedling market include increase in prevalence of various skin condition such as scar, acne, pigmentation; surge in sedentary lifestyle; rise in concern among population regarding aesthetic appearance; and increase in demand for minimal invasive cosmetic procedure. According to the article of Biodermis, in June 2021, around 80% of population aged between 11 and 30 years were reported to have been affected with acne. In addition, increase in life style changes such as erratic sleep pattern, irregular diet, and consumption of alcohol, tobacco, result in acne. Acne is the most common skin problem among population. Thus, dermabrasion and microneedling are aesthetic treatments which are considered for reducing acne scarring.

In addition, Dermabrasion and microneedling market trends include increase in number of medical aesthetic device by major key players, advancement in technology in medical aesthetic sector, increase in number of dermabrasion and microneedling treatment in clinics & hospitals and surge in number of product approvals. For instance, in May 2021, Eclipse, one of the leading aesthetic and medical manufacturers,  announced the U.S Food and Drug Administration (FDA) clearance for the MicroPen EVO. It is one of the advanced medical grade micro-needling devices used in microneedling procedures. Moreover, Sarasin Clinic, offers various Microneedling with radiofrequency aesthetic treatments for skin tightening and reduction of wrinkles.

In addition, rise in demand for anti-aging procedures to reduce fine lines and wrinkles, and increase in health and skin consciousness among population further propels the dermabrasion and microneedling market growth. Moreover, increase in stress among population, and surge in use of chemicals in face further surge the demand for facial rejuvenation treatment and drive the growth of the market. Stress is one of the major causes of acne, due to increase in level of stress hormone such as androgen and cortisone. These hormones act by increasing skin’s oil production which further lead to exacerbate acne. According to the scientific Journal of Medicina, in December 2022, around 58.4% of individual believed that stress induces acne vulgaris.

However, the high cost of dermabrasion procedure and availability of alternative treatment negatively impact the growth of the market.

On the basis of procedure, the market is classified into dermabrasion and microneedling. The dermabrasion segment was the largest revenue contributor to the market in 2021, owing to rise in prevalence of skin disease such as acne scar, and advancement in technology for development of advanced dermabrasion treatment.

On the basis of gender, the market is classified into female and male. The female segment was the highest revenue contributor to the market in 2021, and is the fastest growing segment during the forecast period, due to rise in acceptance and adoption of facial aesthetics procedure female population.

On the basis of application, the market is classified into fine lines and wrinkles, scar, and others. The others segment includes sun-damage, and pigmentation. The scar segment was the largest growing segment in 2021, and is projected to be the fastest growing segment during the forecast period owing to increase in prevalence of acne scar, increase in sedentary life style, and rise in demand for scar treatment among population.

On the basis of end user, the market is classified into specialty and dermatology clinics, hospitals, and others. The others segment includes aesthetic centers, and beauty salon. The hospitals segment dominated the market in 2021 and is expected to remain dominant throughout the forecast period, owing to rise in the adoption of aesthetic procedure in hospitals, and rise in expenditure by government to develop healthcare infrastructure in hospital.

Region wise, North America has the highest dermabrasion and microneedling market share in 2021, and is expected to maintain its lead during the forecast period, owing to increase in number of minimal invasive surgical aesthetic procedure, rise in adoption of advanced aesthetic procedure in hospitals, and surge in prevalence of acne scar and strong presence of dermabrasion and microneedling industry in this region. However, Asia-Pacific is expected to exhibit fastest growth during the forecast period, owing to high prevalence of aging population with increased need of aesthetic surgery, improvement in healthcare awareness, and surge in healthcare expenditure.

Key Findings of The Study

• By procedure, the dermabrasion segment dominated the market in 2021.
• By gender, the female segment dominated the market in 2021.
• By application, the scar operated segment dominated the market in 2021.
• By end user, the hospitals segment dominated the market in 2021.
• By region, North America dominated the market in 2021. However, Asia-Pacific is expected to register highest CAGR during the forecast period.